Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,180 across all filing types
Latest filing 2022-06-17 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Intimation regarding loss of share certificate by the shareholder.
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) 2015, concerning details of a lost share certificate and a request for stop transfer. It is addressed to the stock exchange and signed by the company secretary. The content is a regulatory notification about share certificate status, not a financial report, earnings release, or management discussion. The document length is short (1848 characters) and it is a formal regulatory communication. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-06-17 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements), 2015, related to details of loss of share certificates and stop transfer requests. It is addressed to the stock exchange and signed by the company secretary. The document is short (1635 characters) and serves as a regulatory compliance communication rather than a financial report or announcement of voting results, management changes, or capital changes. It does not contain financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-06-17 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of a new Regional Reference Laboratory by Lupin Diagnostics in Patna, India. It provides details about the company's expansion, services, and background information about Lupin and Lupin Diagnostics. There are no financial statements, regulatory filings, voting results, or management discussions. The content is promotional and informational about a business development rather than a financial report or regulatory announcement. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is best classified as a general Regulatory Filing (RNS) since it is a corporate announcement that does not fit other specific categories.
2022-06-15 English
Lupin Diagnostics Launches its First Regional Reference Laboratory in Patna.
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of Lupin Diagnostics' first Regional Reference Laboratory in Patna, Bihar. It is addressed to stock exchanges and references compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is a corporate announcement about business expansion and does not contain financial statements, earnings data, or detailed financial analysis. It is not a report, transcript, or regulatory filing with substantive financial data. The document is a disclosure announcement about a corporate event, fitting best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-06-15 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements), 2015, addressed to the National Stock Exchange of India. It details the loss of share certificates and the stop transfer request from an investor. The document is short (1657 characters) and is a regulatory compliance communication rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-06-10 English
Disclosure pursuant to loss of share certificate by the shareholder(s).
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding an intimation under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements), 2015. It details the loss of share certificates and requests stop transfer of those shares. The content is a regulatory notification about share certificate status and does not contain financial data, management discussion, or report content. It is a regulatory filing related to compliance and disclosure obligations under SEBI regulations, not a financial report or announcement of voting results or capital changes. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and it is a formal compliance communication.
2022-06-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.